NO20031483L - Vaksine - Google Patents

Vaksine

Info

Publication number: NO20031483L
Authority: NO; Norway
Prior art keywords: vaccine
Prior art date: 2000-10-02

Application number

NO20031483A

Other languages

English (en)

Other versions

NO20031483D0 (no

Inventor

Brigitte Desiree Alberte Colau

Marguerite Deschamps

Original Assignee

Glaxosmithkline Biolog Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-02

Filing date

2003-04-01

Publication date

2003-05-28

2003-04-01 Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa

2003-04-01 Publication of NO20031483D0 publication Critical patent/NO20031483D0/no

2003-05-28 Publication of NO20031483L publication Critical patent/NO20031483L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/165—Mumps or measles virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO20031483A 2000-10-02 2003-04-01 Vaksine NO20031483L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0024089.5A GB0024089D0 (en)	2000-10-02	2000-10-02	Novel compounds
PCT/EP2001/011326 WO2002028422A2 (en)	2000-10-02	2001-10-01	Split enveloped virus preparation for intranasal delivery

Publications (2)

Publication Number	Publication Date
NO20031483D0 NO20031483D0 (no)	2003-04-01
NO20031483L true NO20031483L (no)	2003-05-28

Family

ID=9900509

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031483A NO20031483L (no)	2000-10-02	2003-04-01	Vaksine

Country Status (16)

Country	Link
US (1)	US20040022808A1 (no)
EP (1)	EP1324769A2 (no)
JP (1)	JP2004510744A (no)
KR (1)	KR20030031200A (no)
CN (1)	CN1477971A (no)
AU (1)	AU2002213984A1 (no)
BR (1)	BR0114393A (no)
CA (1)	CA2427842A1 (no)
CZ (1)	CZ2003931A3 (no)
GB (1)	GB0024089D0 (no)
HU (1)	HUP0302643A2 (no)
IL (1)	IL155072A0 (no)
NO (1)	NO20031483L (no)
PL (1)	PL362705A1 (no)
WO (1)	WO2002028422A2 (no)
ZA (1)	ZA200302522B (no)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA05005306A (es)	2003-06-20	2005-10-26	Microbix Biosystems Inc	Mejoramientos en la produccion de virus.
CA2549197C (en)	2003-12-17	2015-04-14	Wyeth	Methods for producing storage stable viruses and immunogenic compositions thereof
CN1305526C (zh) *	2003-12-29	2007-03-21	薛平	乙型脑炎病毒裂解疫苗及其制备方法
EP1722815A1 (en)	2004-03-09	2006-11-22	Chiron Corporation	Influenza virus vaccines
NZ567817A (en)	2005-11-01	2012-01-12	Novartis Vaccines & Diagnostic	Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment
CN102755645A (zh)	2005-11-04	2012-10-31	诺华疫苗和诊断有限公司	佐剂配制的包含细胞因子诱导剂的流感疫苗
NZ568211A (en)	2005-11-04	2011-11-25	Novartis Vaccines & Diagnostic	Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
EP1945252B1 (en)	2005-11-04	2013-05-29	Novartis Vaccines and Diagnostics S.r.l.	Vaccines comprising purified surface antigens prepared from influenza viruses grown in cell culture, adjuvanted with squalene
EP1951302A2 (en)	2005-11-04	2008-08-06	Novartis Vaccines and Diagnostics S.r.l.	Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
NZ568210A (en)	2005-11-04	2012-12-21	Novartis Vaccines & Diagnostic	Emulsions with free aqueous-phase surfactant as adjuvants for split influenza vaccines
JP6087041B2 (ja)	2006-01-27	2017-03-08	ノバルティスアーゲー	血球凝集素およびマトリックスタンパク質を含むインフルエンザウイルスワクチン
US20100068223A1 (en)	2006-03-24	2010-03-18	Hanno Scheffczik	Storage of Influenza Vaccines Without Refrigeration
GB0614460D0 (en)	2006-07-20	2006-08-30	Novartis Ag	Vaccines
CA3016948A1 (en)	2006-09-11	2008-03-20	Seqirus UK Limited	Making influenza virus vaccines without using eggs
US20110053248A1 (en) *	2006-10-23	2011-03-03	Medimmune, Llc	Serum-Free Virus Propagation Platform For A Virus Vaccine Candidate
ES2480491T3 (es)	2006-12-06	2014-07-28	Novartis Ag	Vacunas incluyendo antígeno de cuatro cepas de virus de la gripe
EA201070066A1 (ru)	2007-06-27	2010-06-30	Новартис Аг	Вакцины против гриппа с низким содержанием добавок
CA2696090C (en) *	2007-08-28	2017-06-13	Baxter International Inc.	Method for producing viral vaccines
GB0810305D0 (en)	2008-06-05	2008-07-09	Novartis Ag	Influenza vaccination
NZ586439A (en)	2007-12-24	2012-10-26	Novartis Ag	Method for peforming an immunodiffusion assay (SRID) for influenza hemagglutinin antigen based on desorbing the antigen from the aluminium adjuvant salt
EP2268309B1 (en)	2008-03-18	2015-01-21	Novartis AG	Improvements in preparation of influenza virus vaccine antigens
US20110217330A1 (en)	2008-11-05	2011-09-08	Bruno Rene Andre	Novel method
WO2010079081A1 (en)	2009-01-07	2010-07-15	Glaxosmithkline Biologicals S.A.	Methods for recovering a virus or a viral antigen produced by cell culture
EP2393922A1 (en)	2009-02-06	2011-12-14	GlaxoSmithKline Biologicals S.A.	Purification of virus or viral antigens by density gradient ultracentrifugation
CA2752041A1 (en)	2009-02-10	2010-08-19	Novartis Ag	Influenza vaccines with increased amounts of h3 antigen
EA201500910A1 (ru)	2009-02-10	2016-04-29	Новартис Аг	Вакцины против гриппа со сниженным количеством сквалена
US20120093859A1 (en)	2009-02-10	2012-04-19	Novartis Ag	Influenza vaccine regimens for pandemic-associated strains
CA2763816A1 (en)	2009-04-27	2010-11-04	Novartis Ag	Adjuvanted vaccines for protecting against influenza
SI2401384T1 (sl)	2009-05-21	2013-01-31	Novartis Ag	Reverzna genetika z uporabo neendogenih pol i promotorjev
JP5716297B2 (ja)	2009-06-25	2015-05-13	Jnc株式会社	クロマトグラフィー用充填剤、その製造方法、およびそれを用いたウイルス用ワクチンの製造方法
JP2013500712A (ja)	2009-07-31	2013-01-10	ノバルティスアーゲー	逆遺伝学系
WO2011030218A1 (en)	2009-09-10	2011-03-17	Novartis Ag	Combination vaccines against respiratory tract diseases
JP5774010B2 (ja)	2009-09-25	2015-09-02	グラクソスミスクラインバイオロジカルズソシエテアノニム	インフルエンザウイルスのための免疫拡散アッセイ
EP2491117B2 (en)	2009-10-20	2017-06-28	Novartis AG	Improved reverse genetics methods for virus rescue
JP6200805B2 (ja)	2010-05-03	2017-09-20	グラクソスミスクラインバイオロジカルズソシエテアノニム	新規な方法
JP6072677B2 (ja)	2010-05-06	2017-02-01	ノバルティスアーゲー	微生物の不活化のための有機ペルオキシド化合物
CN103025350A (zh)	2010-05-21	2013-04-03	诺华有限公司	流感病毒的重配方法
BR112012030616A2 (pt)	2010-06-01	2017-03-01	Novartis Ag	concentração de antígenos de vacina com liofilização.
HUE051711T2 (hu)	2010-06-01	2021-03-29	Seqirus Uk Ltd	Influenzavakcina antigénjeinek koncentrálása liofilizálás nélkül
WO2011154976A2 (en)	2010-06-08	2011-12-15	Panacea Biotec Limited	Improved influenza vaccine
ES2531577T3 (es)	2010-08-20	2015-03-17	Novartis Ag	Conjuntos de agujas para la administración de vacuna soluble contra la gripe
GB201216121D0 (en)	2012-09-10	2012-10-24	Novartis Ag	Sample quantification by disc centrifugation
EP2768528A1 (en)	2011-10-20	2014-08-27	Novartis AG	Adjuvanted influenza b virus vaccines for pediatric priming
EP2820126B1 (en)	2012-03-02	2017-05-17	Seqirus UK Limited	Influenza virus reassortment
CN104159608A (zh)	2012-03-06	2014-11-19	克鲁塞尔荷兰公司	针对流感的改善的疫苗接种
AU2013270793A1 (en)	2012-06-04	2014-12-11	Novartis Ag	Improved safety testing
EA201891945A3 (ru) *	2012-08-01	2019-05-31	Бавариан Нордик А/С	Вакцина рекомбинантного модифицированного вируса осповакцины анкара (mva) респираторно-синцитиального вируса (rsv)
GB201218195D0 (en)	2012-10-10	2012-11-21	Istituto Zooprofilattico Sperimentale Delle Venezie	Composition
CA2893429A1 (en)	2012-12-03	2014-06-12	Synthetic Genomics Vaccines, Inc.	Influenza virus reassortment
EP2943221A1 (en)	2013-01-10	2015-11-18	Novartis AG	Influenza virus immunogenic compositions and uses thereof
EP2968512A2 (en)	2013-03-13	2016-01-20	Novartis AG	Influenza b virus reassortment
AU2014264501A1 (en)	2013-05-10	2015-12-10	Novartis Ag	Avoiding narcolepsy risk in influenza vaccines
DE202013005130U1 (de)	2013-06-05	2013-09-10	Novartis Ag	Influenza Virus Reassortierung
DE202013005100U1 (de)	2013-06-05	2013-08-26	Novartis Ag	Influenza Virus Reassortierung
HK1222882A1 (zh)	2013-06-06	2017-07-14	Novartis Ag	流感病毒重配
CA2920934C (en)	2013-08-30	2022-12-06	Glaxosmithkline Biologicals S.A.	Large scale production of viruses in cell culture
KR20160068972A (ko)	2013-11-15	2016-06-15	노파르티스 아게	잔여 세포 배양 불순물의 제거
CN105250280B (zh)	2014-07-14	2020-03-10	诺维科国际控股股份有限公司	包含辛苯聚醇和喹诺里西啶生物碱化合物或其来源的杀微生物组合物
FR3025107B1 (fr)	2014-08-29	2018-10-05	Calixar	Procede de preparation d'un antigene vaccinal, antigene vaccinal obtenu et utilisations
EP3234113B1 (en)	2014-12-16	2019-01-23	GlaxoSmithKline Biologicals S.A.	A method for a large scale virus purification
EP3313439A2 (en)	2015-06-26	2018-05-02	Seqirus UK Limited	Antigenically matched influenza vaccines
KR102576962B1 (ko)	2015-07-07	2023-09-11	세퀴러스 유케이 리미티드	인플루엔자 효능 검정
CN107085095A (zh) *	2017-03-02	2017-08-22	江苏华冠生物技术股份有限公司	用作酶联试剂盒包被抗原的麻疹病毒裂解液的制备方法
BR112021016778A2 (pt)	2019-02-25	2021-11-16	Seqirus Uk Ltd	Vacinas contra influenza multivalentes com adjuvante e usos
WO2020190985A1 (en)	2019-03-19	2020-09-24	Amgen Inc.	Alternate detergents for viral inactivation
EP4054630A2 (en)	2019-11-07	2022-09-14	Seqirus UK Limited	Compositions and methods for producing a viral vaccine with reduced particle size
US20230000971A1 (en)	2019-11-18	2023-01-05	Seqirus Pty Ltd.	Method for producing reassortant influenza viruses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4005528C2 (de) *	1990-02-22	1998-01-15	Pfeiffer Erich Gmbh & Co Kg	Austragvorrichtung für Medien
WO2001021151A1 (en) *	1999-09-24	2001-03-29	Smithkline Beecham Biologicals S.A.	Intranasal influenza virus vaccine

2000
- 2000-10-02 GB GBGB0024089.5A patent/GB0024089D0/en not_active Ceased
2001
- 2001-10-01 IL IL15507201A patent/IL155072A0/xx unknown
- 2001-10-01 JP JP2002532246A patent/JP2004510744A/ja active Pending
- 2001-10-01 KR KR10-2003-7004719A patent/KR20030031200A/ko not_active Withdrawn
- 2001-10-01 EP EP01982385A patent/EP1324769A2/en not_active Withdrawn
- 2001-10-01 CZ CZ2003931A patent/CZ2003931A3/cs unknown
- 2001-10-01 AU AU2002213984A patent/AU2002213984A1/en not_active Abandoned
- 2001-10-01 CA CA002427842A patent/CA2427842A1/en not_active Abandoned
- 2001-10-01 BR BR0114393-0A patent/BR0114393A/pt not_active Application Discontinuation
- 2001-10-01 PL PL01362705A patent/PL362705A1/xx unknown
- 2001-10-01 US US10/381,354 patent/US20040022808A1/en not_active Abandoned
- 2001-10-01 WO PCT/EP2001/011326 patent/WO2002028422A2/en not_active Ceased
- 2001-10-01 HU HU0302643A patent/HUP0302643A2/hu unknown
- 2001-10-01 CN CNA018198074A patent/CN1477971A/zh active Pending
2003
- 2003-03-31 ZA ZA200302522A patent/ZA200302522B/en unknown
- 2003-04-01 NO NO20031483A patent/NO20031483L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2427842A1 (en)	2002-04-11
ZA200302522B (en)	2004-06-30
KR20030031200A (ko)	2003-04-18
NO20031483D0 (no)	2003-04-01
WO2002028422A3 (en)	2002-08-29
EP1324769A2 (en)	2003-07-09
PL362705A1 (en)	2004-11-02
WO2002028422A2 (en)	2002-04-11
CN1477971A (zh)	2004-02-25
US20040022808A1 (en)	2004-02-05
JP2004510744A (ja)	2004-04-08
BR0114393A (pt)	2003-08-26
CZ2003931A3 (cs)	2003-10-15
IL155072A0 (en)	2003-10-31
HUP0302643A2 (hu)	2003-11-28
AU2002213984A1 (en)	2002-04-15
GB0024089D0 (en)	2000-11-15

Publication	Publication Date	Title
NO20031483D0 (no)	2003-04-01	Vaksine
NO20024172L (no)	2002-11-01	Vaksine
PL363005A1 (pl)	2004-11-15	Szczepionki
NO20026175L (no)	2003-02-26	Vaksinesammensetning
NO20031705D0 (no)	2003-04-11	Vaksiner
NO20014325D0 (no)	2001-09-05	Vaksine
ATE290000T1 (de)	2005-03-15	Muscarinagonisten
ATE252099T1 (de)	2003-11-15	Biarylcarboxamide
ATE312098T1 (de)	2005-12-15	Thiazinoxazolidinon
ATA2932001A (de)	2004-11-15	Schneefräse
DK1427444T3 (da)	2013-11-04	West-nil-vaccine
DE60002650D1 (de)	2003-06-18	Öladjuvierter Impfstoff
NO20020763D0 (no)	2002-02-15	Vaksine
NO20033882D0 (no)	2003-09-02	Vaksine
ATE262530T1 (de)	2004-04-15	Indolochinazolinone
ATE298751T1 (de)	2005-07-15	7-oxopyridoryrimidine
AR028336A1 (es)	2003-05-07	4-hidroxi-tetrahidropiridonas fenilsubstituidas
ATE509008T1 (de)	2011-05-15	Sulfonylguanidine
NO20024322L (no)	2002-09-10	Sekvens
AR028061A1 (es)	2003-04-23	2-enamino-cetonitrilos fenil-substituidos
AR027931A1 (es)	2003-04-16	Antitranspirantes
ATE476423T1 (de)	2010-08-15	Benzoylpyridazine
ATE284887T1 (de)	2005-01-15	Thienopyrrolidinone
ATA7092001A (de)	2004-08-15	Skibindungseinstellgerät
AT500246B8 (de)	2007-02-15	Chokerring

Legal Events

Date	Code	Title	Description
2005-06-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application